![Sijmen de Vries](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sijmen de Vries
Direktor/Vorstandsmitglied bei
BIODEXA PHARMACEUTICALS PLC
Vermögen: - $ am 31.07.2026
Profil
Sijmen de Vries is currently Chief Executive Officer at Pharming Intellectual Property BV, Non-Executive Director at Sylus Pharmaceuticals Ltd. since 2010, Independent Non-Executive Director at Biodexa Pharmaceuticals Plc since 2014, and Finish Partner at BioConnection BV.
Former roles include Chief Executive Officer at Morphochem AG and 4-Antibody AG, Executive Director at Pharming Group NV from 2008 to 2025, and Non-Executive Director at Biodexa Ltd. from 2004 to 2015.
Education includes a doctorate from the University of Amsterdam and an MBA from Ashridge Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.03.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Sijmen de Vries
| Unternehmen | Position | Beginn |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 13.11.2014 |
Sylus Pharmaceuticals Ltd. | Direktor/Vorstandsmitglied | 21.06.2010 |
Pharming Intellectual Property BV
 Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures milking equipment | Vorstandsvorsitzender | - |
BioConnection BV
 BioConnection BV BiotechnologyHealth Technology Provides biopharmaceutical services | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Sijmen de Vries
| Unternehmen | Position | Ende |
|---|---|---|
| PHARMING GROUP N.V. | Vorstandsvorsitzender | 04.03.2025 |
Midatech Ltd.
 Midatech Ltd. BiotechnologyHealth Technology Engages in discovery and the development of nanomedicine pharmaceutical products | Direktor/Vorstandsmitglied | 13.03.2015 |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Vorstandsvorsitzender | - |
Morphochem AG
 Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Vorstandsvorsitzender | - |
Ausbildung von Sijmen de Vries
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Commercial Services |
University of Amsterdam
 University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Ashridge Business School
 Ashridge Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Engages in discovery and the development of nanomedicine pharmaceutical products | Health Technology |
Sylus Pharmaceuticals Ltd. | |
Biodexa Pharmaceuticals Plc
 Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures milking equipment | Producer Manufacturing |
